[1]胡丽丽,李小东,张雪宁,等.影像引导下125I粒子植入治疗肺癌的疗效分析[J].国际放射医学核医学杂志,2013,37(4):203-206.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
　HU Li-li,LI Xiao-dong,ZHANG Xue-ning,et al.Efficacy of CT guided radioactive 125I seed implantation in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):203-206.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
点击复制

影像引导下125I粒子植入治疗肺癌的疗效分析(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
37
期数:
2013年第4期
页码:
203-206
栏目:
论著
出版日期:
2013-07-25

文章信息/Info

Title:
Efficacy of CT guided radioactive 125I seed implantation in the treatment of lung cancer
作者:
胡丽丽1;  李小东2;  张雪宁1;  牛冬梅1;  杨景奎3;  时代1;  王琳2;  苏倩2
1. 300074 天津, 天津市儿童医院放射科;
2. 300211 天津, 天津市医科大学第二医院放射治疗科;
3. 300211 天津, 天津市医科大学第二医院放射科
Author(s):
HU Li-li1;  LI Xiao-dong2;  ZHANG Xue-ning1;  NIU Dong-mei1;  YANG Jing-kui3;  SHI Dai1;  WANG Lin2;  SU Qian2
Department of Radiology, Tianjin Children’s Hospital, Tianjin 300074, China
关键词:
肺肿瘤; 碘放射性同位素; 近距离放射疗法; 体层摄影术; X线计算机
Keywords:
Lung neoplasms; Iodine radioisotopes; Brachytherapy; Tomography; X-ray computed
DOI:
10.3760/cma.j.issn.1673-4114.2013.04.004
摘要:
目的 探讨CT引导下经皮穿刺125I粒子植入治疗晚期肺癌的可行性、疗效及并发症情况。方法 根据治疗方法的不同,将65例晚期肺癌患者分为2组,单纯植入粒子组37例,行单纯CT引导下125I粒子植入治疗;联合组28例,行125I粒子植入治疗联合泽菲和顺铂化疗,两组患者术后均行剂量学验证,并定期随访复查。结果 65例患者术后总有效率为80.0%,1年生存率为90.8%,单纯植入粒子组与联合组的有效率分别为67.6%和96.4%,两组之间差异有统计学意义(χ2=8.298,P<0.01)。所有患者治疗前肿瘤平均直径为5.48 cm,治疗后为3.77 cm,治疗前、后差异有统计学意义(t=7.764,P<0.01)。65例患者术后36例出现气胸,7例出现血痰,4例出现发热,对症处理后均好转;未出现放射性肺炎等。结论 125I粒子植入治疗晚期肺癌的近期疗效肯定,无严重并发症。
Abstract:
Objective To investigate the feasibility,efficacy and complications of CT guided radioactive 125I seed implantation in the treatment of lung cancer.Methods According to the different treatment methods,65 patients with lung cancer were divided into two groups,37 cases in the implantation alone group received CT guided 125I seeds interstitial implantation,the other 28 cases in the combination treatment group received interstitial 125I seeds implantation combined with chemotherapy.All the patients were examined by posologic validation,and were followed up termly.Results The total effictive rate of 65 patients was 80.0%,1-year survival rate was 90.8%.The effictive rates of implantation alone group and combination treatment group were 67.6% and 96.4% respectively.There was a significant difference between the two groups (χ2=8.298,P<0.01).Before treatment,all the patients’ mean diameter of the tumor was 5.48 cm; while it was 3.77 cm after treatment (t=7.764,P<0.01).Complications included pneumothorax (36 cases),bloody sputum (7 cases),fever (4 cases) which improved after treatment in 65 patients,but without radiation pneumonia.Conclusion 125I seed implantation is a highly effective treatment without severe complications in the treatment of lung cancer.

参考文献/References:

[1] 李小东,郭永涛,张遵城,等. 125I粒子植人治疗晚期肺癌的损伤效应与临床处置. 中华放射医学与防护杂志,2007,27(6):565-567.
[2] Zhongmin W, Yu L, Fenju L, et al. Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. Eur Radiol, 2010, 20(7):1786-1791.
[3] Hilaris BS, Martini N. Interstitial brachytherapy in cancer of the lung:a 20 year experience. Int J Radiat Oncol Biol Phys, 1979, 5(11-12):1951-1956.
[4] Parashar B, Patel P, Monni S, et al. Limited resection followed by intraoperative seed implantation is comparable to stereotactic body radiotherapy for solitary lung cancer. Cancer, 2010, 116(21):5047-5053.
[5] Nakamura H, Kawasaki N, Hagiwara M, et al. Early hilar lung cancer-risk for multiple lung cancers and clinical outcome. Lung Cancer, 2001,33(1):51-57.
[6] 梁吉祥,柴树德. 郑广钧,等. CT引导下植入125I粒子治疗非小细胞肺癌切除术后局部复发的疗效. 国际放射医学核医学杂志,2011,35(3):181-185.
[7] Colonias A, Betler J, Trombetta M, et al. Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys, 2011,79(1):105-109.
[8] Fernando 11C, Landreneau RJ, Mandrekar SJ, et al. Thirty-and ninety-day outcomes after sublobar resection with and without brachytheiapy for non-small cell lung cancer:results from a multicenter phase III study. J Thorac Cardiovasc Surg, 2011,142(5):1143-1151.
[9] Ye SJ, Brezovich IA, Shen S, et al. Dose errors due to inhomogeneities in balloon catheter brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys, 2004,60(2):672-677.
[10] 孙民峰,郝长城,梁昌胜,等. CT引导下I粒子植入治疗48例肺癌分析. 肿瘤学杂志,2011,12(17):951-952.

相似文献/References:

[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
　Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
　Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[3]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
　Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[4]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
　Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[5]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
　yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[6]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
　Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[7]刘娇,程兵,常伟,等.非高危分化型甲状腺癌低剂量和高剂量131I清甲疗效的分析[J].国际放射医学核医学杂志,2016,40(6):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
　Liu Jiao,Cheng Bing,Chang Wei,et al.Ablation efficacy in non-high-risk differentiated thyroid carcinoma patients with low-dose and high-dose 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
[8]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
　Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[9]王越,晋建华,李思进,等.甲状腺24h摄碘率与131I治疗Graves甲亢疗效相关性研究[J].国际放射医学核医学杂志,2015,39(6):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
　Wang Yue,Jin Jianhua,Li Sijin,et al.Correlation between thyroid 24 h of radioactive iodine uptake and clinical efficacy of 131I therapy for Graves’ hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
[10]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
　Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[11]张俊涛.晚期肺癌125I粒子植入治疗近期疗效观察[J].国际放射医学核医学杂志,2014,38(2):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
　Zhang Juntao.Short-term efficacy of 125I seeds implantation in the treatment of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
[12]廖江荣,蒲德利,程毅力,等.经纤支镜和经皮联合植入125I粒子治疗晚期肺癌气管狭窄的临床分析[J].国际放射医学核医学杂志,2013,37(3):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
　LIAO Jiang-rong,PU De-li,CHENG Yi-li,et al.The clinical analysis of 125I particles implantation by fibrobronchoscope and percutaneous in the treatment of tracheal stenosis of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
[13]姚红霞,张金山.微波消融和131I-肿瘤细胞核人鼠嵌合单克隆抗体联合治疗肺癌[J].国际放射医学核医学杂志,2012,36(5):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
　YAO Hong-xia,ZHA NG Jin-shan.Combination of microwave ablation and 131I labeled tumor necrosis therapy chimeric antibody in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
[14]朱晓珉,方文岩,陈军,等.CT导向下125I粒子植入治疗难治生肺癌的疗效观察[J].国际放射医学核医学杂志,2011,35(2):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
　ZHU Xiao-min,FANG Wen-yan,CHEN Jun,et al.CT guided interstitial 125I seed implantation treatment of refractory lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
[15]张金山,邓咏梅.射频消融术和131I-肿瘤细胞核人鼠嵌合单抗治疗肺癌[J].国际放射医学核医学杂志,2009,33(3):159.[doi:10.3760/cma.j.issn.1673-4114.2009.03.008]
　ZHA NG din-shan,DENG Yong-mei.Radiofrequency ablation and Iodine-131 labeled nuclei of tumor cells chimeric monoclonal antibody radioimmunotherapy for the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):159.[doi:10.3760/cma.j.issn.1673-4114.2009.03.008]
[16]刘建国,安丽青,程劲光,等.纤维支气管镜下植入125I粒子治疗中央型肺癌[J].国际放射医学核医学杂志,2009,33(5):291.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.011]
　LIU Jian-guo,AN Li-qing,CHENG Jin-guang,et al.Efficacies of 125I seed implantation in advanced stage central lung cancer via fibrobronchoscope[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):291.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.011]

备注/Memo

备注/Memo:
收稿日期:2013-04-24。
通讯作者:李小东,Email:lixiaodonglxd@163.com
更新日期/Last Update: 1900-01-01